ID   NS0bcl-2
AC   CVCL_DD16
SY   NSObcl-2; NS0 Bcl-2; NSO-Bcl-2; NSO-bcl2; NS0-bcl2
DR   Wikidata; Q54931048
RX   Patent=US5565337;
RX   PubMed=8202525;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11705.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:990; BCL2.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 9
//
RX   PubMed=8202525; DOI=10.1073/pnas.91.12.5548; PMCID=PMC44033;
RA   Ray, Subhransu
RA   Diamond, Betty A.
RT   "Generation of a fusion partner to sample the repertoire of splenic B
RT   cells destined for apoptosis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:5548-5551(1994).
//
RX   Patent=US5565337;
RA   Diamond, Betty A.
RA   Ray, Subhransu
RT   "Hybridoma-producing NSO myeloma cell line.";
RL   Patent number US5565337, 15-Oct-1996.
//